<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Emerging evidence indicates that the miR-17 family may have a causal role in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, but their specific effects on the occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>) are still poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we profiled <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue samples by miRNA (microRNA) microarray and found that four members of the miR-17 family had higher expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues than in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="2" pm="."><plain>This finding was further validated by qRT-PCR (quantitative reverse transcription PCR) </plain></SENT>
<SENT sid="3" pm="."><plain>Transfecting <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells with an inhibitor of miR-17 lowered their ability to proliferate and induced G0/G1 arrest </plain></SENT>
<SENT sid="4" pm="."><plain>We also confirmed that miR-17 exerted this function by directly targeting RND3 in vitro, and that the expression of miR-17 was negatively correlated with that of RND3 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, miR-17 inhibition led to <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> suppression and up-regulation of RND3 expression in a <z:mp ids='MP_0003815'>nude</z:mp> mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RND3 expression was found to be significantly lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues than in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and <z:mpath ids='MPATH_270'>adenomas</z:mpath>, indicating that RND3 may act as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, the present study suggests that miR-17 plays an important role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> by targeting RND3 and may be a therapeutic agent for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>